星空传媒91传媒制片厂|明星换脸五级片|麻豆传媒映画女演员王茜|麻豆在传媒在线|九九国产|91制片厂在线观看一二区|夜夜草视频|四虎影院在线播放|国产精品亚洲国际在线看|大象传媒国产第一页,麻豆映画传媒有免费的吗,91制片厂安卓,亚洲成年人精选,91你懂得国产,爱豆视传媒短视频免费,免费一级片

Zhongshan Zhiben Pharmaceutical Technology Co, a company in Cuiheng New District, announced that ZB-001, a new antibacterial drug co-developed by the company with the Shanghai Institute of Materia Medica, has been approved for clinical trials by the Center for Drug Evaluation.

ZB-001 is intended for the treatment of simple gonorrhea and other bacterial infections. It is expected to provide a new solution to bacterial resistance (gonococcus, staphylococcus aureus, etc).

Established in 2021 with the support of SIMM and the Zhongshan Institute for Drug Discovery, Zhiben focuses on the research and development of small molecule innovative drugs.

From 2023, Cuiheng New District will earmark 50 million yuan every year to support 10-20 start-up innovative drug R&D teams.